Thursday, October 8, 2026

HomeHealth NewsHow scientists redesigned an effective cancer therapy to make it safer

How scientists redesigned an effective cancer therapy to make it safer

- Advertisement -

EBD-200 presents a surface more similar to that presented by hA and has optimal in vivo asparaginase kinetic properties with no L-GLNase co-activity resulting in an improved toxicity profile compared to PEG-ASNase EBD-200 presents a surface that is significantly more identical to the surface of the human asparaginase homolog compared to the E. coli asparaginase…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed